Machine learning and artificial intelligence for the diagnosis of infectious diseases in immunocompromised patients

Abstract

Purpose of review Immunocompromised patients are at high risk for infection. During the coronavirus disease (COVID-19) pandemic, immunocompromised patients exhibited increased odds of intensive care unit admission and death. Early pathogen identification is essential to mitigating infection related risk in immunocompromised patients. Artificial intelligence (AI) and machine learning (ML) have tremendous appeal to address unmet diagnostic needs. These AI/ML tools often rely on the wealth of data found in healthcare to enhance our ability to identify clinically significant patterns of disease. To this end, our review provides an overview of the current AI/ML landscape as it applies to infectious disease testing with emphasis on immunocompromised patients. Recent findings Examples include AI/ML for predicting sepsis in high risk burn patients. Likewise, ML is utilized to analyze complex host-response proteomic data to predict respiratory infections including COVID-19. These same approaches have also been applied for pathogen identification of bacteria, viruses, and hard to detect fungal microbes. Future uses of AI/ML may include integration of predictive analytics in point-of-care (POC) testing and data fusion applications. Summary Immunocompromised patients are at high risk for infections. AI/ML is transforming infectious disease testing and has great potential to address challenges encountered in the immune compromised population.

The 2023 Report on the Proteome from the HUPO Human Proteome Project

“…Pathology is the core medical discipline to bring proteomics to patients via a new class of “postgenomic” protein-directed assays for early disease detection, risk prediction, choice of therapy and combination therapies, and surveillance. Combined with improvements in instrument design, orthogonal , and multiomic approaches, − rapid progress in advanced computational capabilities including AI and machine learning ,− can now facilitate the development of personalized/precision medicine for the improvement of human health. ,, …”

Edge AI for Early Detection of Chronic Diseases and the Spread of Infectious Diseases: Opportunities, Challenges, and Future Directions

“…Several studies have investigated the use of AI for the early detection of chronic diseases such as cardiovascular disease, diabetes, cancer, and infectious diseases [14,15,[45][46][47][48][49][50][51][52]. These research efforts highlight the ability of AI to significantly improve public health outcomes by allowing health professionals to detect chronic diseases in their early stages when interventions are most effective.…”

Evaluating the Performance of Artificial Intelligence in Generating Differential Diagnoses for Infectious Diseases Cases: A Comparative Study of Large Language Models

“…Prior studies have highlighted the efficacy of machine learning (ML) and AI in infectious disease diagnostics, especially in immunocompromised patients who are at a higher risk for severe infections. [4]…”

“…Prior studies have highlighted the efficacy of machine learning (ML) and AI in infectious disease diagnostics, especially in immunocompromised patients who are at a higher risk for severe infections. [4] AI and ML are transforming various fields, including medicine and infectious diseases, with a particular focus on explainable AI/ML models for better understanding and managing these diseases. [5] AI advancements could automate image analysis for pathogen identification and classification of colony growth to enhance diagnostic accuracy and efficiency.…”